Conversion of Osteoclasts into Bone-Protective, Tumor-Suppressing Cells.

Area of Science:

• Oncology
• Cell Biology
• Bone Biology

Background:

• Osteoclasts contribute to bone destruction in breast cancer metastasis.
• Wnt signaling activation is explored as a therapeutic strategy.

Purpose of the Study:

• To investigate if Wnt signaling activation can convert osteoclasts into bone protectors.
• To assess the anti-tumor and anti-metastatic effects of Wnt-activated osteoclast-conditioned medium.

Main Methods:

• RAW264.7 pre-osteoclast cells were activated with Wnt signaling using BML284.
• Conditioned medium (BM CM) from activated cells was tested on mammary tumor cells (EO771) and in a mouse model.
• Effects on osteoclast and osteoblast differentiation were analyzed.
• Protein interactions (Hsp90ab1, enolase 1, LAP-TGFβ, CD44) were studied.

Main Results:

• Wnt-activated BM CM inhibited mammary tumor cell proliferation, migration, and invasion.
• BM CM reduced tumor progression, osteolysis, and lung metastasis in mice.
• BM CM inhibited osteoclast differentiation and enhanced osteoblast differentiation.
• Hsp90ab1 and enolase 1 were identified as key tumor-suppressing proteins in BM CM, interacting with CD44.

Conclusions:

• Wnt signaling activation converts osteoclast-derived conditioned medium into a bone-protective and tumor-suppressing agent.
• Osteoclasts may function as bone protectors, offering unconventional strategies against bone metastasis.
• The findings highlight a novel therapeutic avenue for managing breast cancer bone metastasis.